Page last updated: 2024-08-22

vidarabine and Adenoviridae Infections

vidarabine has been researched along with Adenoviridae Infections in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (25.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartelink, IH; Bierings, MB; Boelens, JJ; de Wildt, A; Gerhardt, CE; Lindemans, CA; van Maarseveen, EM; van Reij, EM; Versluys, B	1
Cavalli-Björkman, N; Gruber, A; Kalin, M; Lundin, J; Osby, E; Osterborg, A	1
Ljungman, P	1
Endo, S; Kurimoto, M; Kurokawa, M; Kurosaki, K; Miwa, N; Shiraki, K; Yoshida, Y	1
Carter, TH; Leonard, TB; Rose, KM	1
Hiraoka, A; Karasuno, T; Kawakami, M; Maeda, T; Masaoka, T; Nakamura, H; Tanaka, K; Teshima, H; Ueda, S	1
Fujioka, T; Hirabayashi, N; Ikegame, K; Kawakami, M; Murakami, M; Ogawa, H; Soma, T; Sugiyama, H; Takahashi, R; Takimoto, T; Tamaki, H	1
Joseph, NH; Laibson, PR; Satz, JE; Waring GO, Ed	1

Reviews

1 review(s) available for vidarabine and Adenoviridae Infections

Article	Year
Treatment of adenovirus infections in the immunocompromised host. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:8 Topics: Adenoviridae Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Organ Transplantation; Organophosphonates; Organophosphorus Compounds; Prognosis; Ribavirin; Severity of Illness Index; Transplantation Immunology; Treatment Outcome; Vidarabine	2004

Article

Year

Treatment of adenovirus infections in the immunocompromised host.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:8

Topics: Adenoviridae Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Organ Transplantation; Organophosphonates; Organophosphorus Compounds; Prognosis; Ribavirin; Severity of Illness Index; Transplantation Immunology; Treatment Outcome; Vidarabine

2004

Other Studies

7 other study(ies) available for vidarabine and Adenoviridae Infections

Article	Year
Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014, Volume: 20, Issue:3 Topics: Adenoviridae Infections; Adolescent; Busulfan; Child; Child, Preschool; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Lung; Male; Myeloablative Agonists; Roseolovirus Infections; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Young Adult	2014
Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia. Medical oncology (Northwood, London, England), 2002, Volume: 19, Issue:4 Topics: Adenoviridae Infections; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine	2002
Therapeutic basis of vidarabine on adenovirus-induced haemorrhagic cystitis. Antiviral chemistry & chemotherapy, 2004, Volume: 15, Issue:5 Topics: Acyclovir; Adenoviridae; Adenoviridae Infections; Antiviral Agents; Cystitis; Dose-Response Relationship, Drug; Hemorrhage; Humans; Immunocompromised Host; Urinary Bladder; Vidarabine; Viral Proteins	2004
Effects of adenine nucleosides on RNA synthesis in adenovirus-infected cells. 9-beta-D-Arabinofuranosyladenine as a selective inhibitor of RNA polyadenylation. Molecular pharmacology, 1982, Volume: 22, Issue:2 Topics: Adenoviridae Infections; Animals; Deoxyadenosines; In Vitro Techniques; Poly A; RNA; RNA, Viral; Vidarabine	1982
Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone marrow transplantation, 1997, Volume: 20, Issue:6 Topics: Adenoviridae Infections; Adult; Bone Marrow Transplantation; Cystitis; Female; Hematuria; Hemorrhage; Humans; Male; Middle Aged; Polyomavirus Infections; Urine; Vidarabine	1997
Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation. International journal of hematology, 2001, Volume: 74, Issue:1 Topics: Adenoviridae Infections; Adenoviruses, Human; Antilymphocyte Serum; Bronchoalveolar Lavage Fluid; Busulfan; Cystitis; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Lymphocyte Count; Lymphocyte Subsets; Male; Methylprednisolone; Middle Aged; Pneumonia, Viral; T-Lymphocytes; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2001
Use of vidarabine in epidemic keratoconjunctivitis due to adenovirus types 3, 7, 8, and 19. American journal of ophthalmology, 1976, Volume: 82, Issue:5 Topics: Adenoviridae Infections; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Cytopathogenic Effect, Viral; Disease Outbreaks; Humans; Keratoconjunctivitis; Pennsylvania; Serotyping; Vidarabine	1976